Terminology Service for NFDI4Health
Carcinoembryonic Antigen Peptide 1-6D
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2622
A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA. [ ]
Term info
Label
Carcinoembryonic Antigen Peptide 1-6D
Synonyms
- CAP-1-6D Peptide
- CEA:571-579 (576D)
- Carcinoembryonic Antigen Peptide 1-6D
- Modified CEA Peptide
- mCEA Peptide
Subsets
NCIT_C128784
Has Target
http://purl.obolibrary.org/obo/NCIT_C25159
Legacy Concept Name
CEA_571-579_Peptide
NSC Code
701524
PDQ Open Trial Search ID
38236
Preferred Name
Carcinoembryonic Antigen Peptide 1-6D
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C0935801
code
C2622
Term relations
Subclass of:
- Carcinoembryonic Antigen Peptide
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation